Codexis Inc — Cash Flow (NASDAQ:CDXS) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities -16.46 M-14.27 M11.28 M-52.64 M-49.41 M -55.94 M Cash from investing activities -5.75 M-21.42 M-13.58 M-4.86 M-56.98 M 14.93 M Cash from financing activities 80.81 M3.77 M-575 K8.17 M60.52 M 28.88 M Free cash flow -20.21 M-28.09 M2.98 M-57.06 M-53.72 M -61.66 M

Codexis Inc

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Новости

Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates

Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue Estimates

Incyte (INCY) Q4 Earnings Lag Estimates

Главный научный директор Codexis Стефан Лутц продал акции на $7 949

Codexis CSO Stefan Lutz sells $7949 in shares

Opaleye Management продает акции Codexis на $1,87 млн

Opaleye Management продает акции Codexis на сумму $877 846

Opaleye management sells Codexis (CDXS) shares for $1.87 million

Opaleye management sells Codexis (CDXS) shares worth $877,846

Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)

Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday